Sources: US News
The Therapeutic Goods Administration grants provisional approval for Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug. 2022-01-20
Switzerland signs an agreement with Pfizer to supply a total of 14 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which also includes an option to supply an additional 7 million vaccine doses in subsequent years. 2021-08-25
In a study published by the National Health Service, the Pfizer vaccine has been found to reduce hospitalizations in elderly people by 75%. 2021-04-14
Pfizer says that they plan to develop new vaccines for other viruses following the success of their COVID-19 vaccine candidate. 2021-03-23
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Supreme Leader Ali Khamenei calls for a ban on the American Pfizer and British AstraZeneca vaccines. 2021-01-8
Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain its plan to administer two doses per person of the COVID-19 vaccine tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy. 2021-01-4
Switzerland begins a mass vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine tozinameran. A ninety-year-old woman in Lucerne is the first Swiss citizen to receive the vaccine. 2020-12-23
Pfizer and BioNTech say that their potential vaccine is 90% effective at preventing COVID-19 infections. 2020-11-9
The government announces that they have signed a deal with Pfizer and BioNTech to purchase 1.5 million vaccine doses for 750,000 people in the country. 2020-10-11